This week, President Donald Trump announced the next in a long line of vanity projects: TrumpRX, a forthcoming, federally branded website where Pfizer sells steeply discounted drugs in exchange for a three-year exemption from his proposed 100 percent tariffs on imported pharmaceuticals. Imagine a strip mall furniture store with a permanent, flashy 70-percent-off sale, masking the fact that prices were inflated in the first place. TrumpRx, slated to launch in early 2026, is no different—a government-run platform that promises savings while hiding costs.

But this isn't just another Trump-branded vanity project like the ill-fated Trump Steaks or Trump University. It's a wild pivot in right-leaning political thought on health care, and it's a gut punch for those who see where this road leads.

See Full Page